5 Papers
13 Citations
David Hui is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Palliative care & Randomized controlled trial. The author has an hindex of 5, co-authored 5 publications. Previous affiliations of David Hui include University of Texas at Austin.
Chat about Author
Papers
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
David Hui,Susan Frisbee-Hume,Annie Wilson,Seyedeh Dibaj,Thuc Nguyen,Maxine de la Cruz,Paul Walker,Donna S. Zhukovsky,Marvin Omar Delgado-Guay,Marieberta Vidal,Daniel E. Epner,Akhila Reddy,Kimerson Tanco,Janet L. Williams,Stacy Hall,Diane Liu,Kenneth R. Hess,Sapna Amin,William Breitbart,Eduardo Bruera +19 more
TL;DR: In this preliminary trial of hospitalized patients with agitated delirium in the setting of advanced cancer, the addition of lorazepam to haloperidol compared with haloperodol alone resulted in a significantly greater reduction in agitation at 8 hours.
181
Benzodiazepines for Agitation in Patients with Delirium: Selecting the Right Patient, Right Time and Right Indication
TL;DR: Benzodiazepines are powerful medications associated with considerable risks and benefits and clinicians should exercise great caution because of the risks of precipitating or worsening delirium and over-sedation.
47
The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
David Hui,Kenneth R. Hess,Seyedeh Dibaj,Joseph Arthur,Rony Dev,Shalini Dalal,Suresh K. Reddy,Eduardo Bruera +7 more
TL;DR: The objective of the current study was to identify the MCID for RASS using 2 anchor‐based approaches.
13
Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report
Edith A. Monreal-Carrillo,Silvia Ros Allende-Pérez,David Hui,Maria Fernanda Garcia-Salamanca,Eduardo Bruera,Emma Verastegui +5 more
TL;DR: The BIS is a noninvasive, bedside, real-time continuous monitoring method that may facilitate the objective assessment of level of consciousness and dose titration in patients undergoing PS.
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.
Bernard Lobato Prado,Diogo Bugano Diniz Gomes,Pedro Luiz Serrano Uson Junior,Patricia Taranto,Monique Sedlmaier Franca,Daniel Eiger,Rodrigo Coutinho Mariano,David Hui,Auro Del Giglio +8 more
TL;DR: PS is a relatively common practice in the end-of-life of cancer patients at the institution and it is not associated with shortening of hospital stay and further research is needed to identify factors that may affect the frequency and outcomes associated with PS.